IBJNews

Lilly offering buyouts to 4,000 sales reps

Back to TopCommentsE-mailPrintBookmark and Share
Indianapolis-based Eli Lilly and Co. today said it is offering buyouts to its U.S. sales force, with hopes of trimming about 300 sales representatives before a sales restructuring set to begin in January, Reuters reported.

A company spokesman told Reuters about 4,000 Lilly employees will be eligible for the program.

"We're trying to lower our headcount ahead of the restructuring and get us closer to the desired number," Lilly spokesman Ed Sagebiel told Reuters.

He said the offers have been extended to representatives in the company's U.S. diabetes, neuroscience and osteoporosis sales force.

The restructuring, to be announced in November and begin in January, will reduce the size of Lilly's sales territories. Smaller territories, each with one sales representative, would allow a better focus on the fewer doctors within each of the tapered regions, Sagebiel told Reuters.

The reductions also are a response to the scheduled 2011 U.S. patent expiration on Lilly's best-selling Zyprexa schizophrenia drug, Sagebiel confirmed.

The company needs to replace nearly 60 percent of the revenue it will lose between 2011 and 2014 when patents on Zyprexa and other top drugs become available to cheaper generic competitors.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT